Carlisle Cos. (CSL) Tops Q4 EPS by 13c
Carlisle Cos. (NYSE: CSL) reported Q4 EPS of $1.24, $0.13 better than the analyst estimate of $1.11. Revenue for the quarter came in at $876.2 million versus the consensus estimate of $863.2 million.
Chris Koch, President and Chief Executive Officer, said, “I am pleased to report Carlisle’s record-setting results in 2015. Under Dave Roberts’ leadership in 2015, we achieved record net sales, record EBIT (earnings before interest and income taxes), record EBIT margin, record net cash provided by operating activities and record income from continuing operations. Our EBIT margin in 2015 grew 150 basis points to 14.2%. Moreover, 2015 marked the formation of two new growth platforms – the fluid handling technologies business in the CFT segment and the medical technology business in the CIT segment. These are high quality businesses that we will further build out, through organic growth efforts and acquisitions, providing additional value to shareholders."
For earnings history and earnings-related data on Carlisle Cos. (CSL) click here.